Patents by Inventor Antoine Noujiam

Antoine Noujiam has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and Methods for Producing Vascular Occlusion using a Solid-phase Platelet Binding Agent
    Publication number: 20160074482
    Abstract: The present invention relates generally to methods and compositions for targeting and delivering solid-phase platelet-dependent vascular occlusion agents. In particular, particles or coils or stents coated with platelet binding agents are directed to target vasculature, such as the vasculature of solid tumor masses or AV-malformations or aneurysms or endoleaks; the solid-phase agent then binds and activates platelets, which in turn bind and activate other platelets. This process results in the rapid formation of a platelet-mediated thrombus about the solid-phase agent causing vessel occlusion.
    Type: Application
    Filed: March 25, 2015
    Publication date: March 17, 2016
    Inventors: Michael W. Stewart, Roland H. Person, Irwin J. Griffith, Paul B. Tiege, Antoine Noujiam
  • Cleavable carnitine compound
    Patent number: 8318954
    Abstract: The invention includes novel compounds, including but not limited to formula A and formula B, and an improved delivery method. These compounds and methods are useful in preventing or treating diseases or conditions associated with or caused by the presence of free radicals, and are useful for increasing cellular metabolism while simultaneously alleviating the resultant increase in oxidative stress. Specifically, a carnitine is bound to a lipoic acid derivative or to dihydrolipoic acid or its derivatives using a hydrolysable linker to form a single compound.
    Type: Grant
    Filed: February 23, 2007
    Date of Patent: November 27, 2012
    Assignee: Nou Life Sciences, Inc.
    Inventors: Inder Pal Singh, Shradha Singh, Antoine Noujiam, Bruce D. Hirsche, legal representative, David S. Tam
  • Compositions and Methods for Producing Vascular Occlusion using a Solid-phase Platelet Binding Agent
    Publication number: 20110135736
    Abstract: The present invention relates generally to methods and compositions for targeting and delivering solid-phase platelet-dependent vascular occlusion agents. In particular, particles or coils or stents coated with platelet binding agents are directed to target vasculature, such as the vasculature of solid tumor masses or AV-malformations or aneurysms or endoleaks; the solid-phase agent then binds and activates platelets, which in turn bind and activate other platelets. This process results in the rapid formation of a platelet-mediated thrombus about the solid-phase agent causing vessel occlusion.
    Type: Application
    Filed: November 26, 2008
    Publication date: June 9, 2011
    Inventors: Michael W. Stewart, Roland H. Person, Irwin J. Griffith, Paul B. Tiege, Antoine Noujiam, Bruce Hirsche
  • Compositions and Methods for Producing Vascular Occlusion Using a Solid-Phase Platelet Binding Agent
    Publication number: 20080160063
    Abstract: The present invention relates generally to methods and compositions for targeting and delivering solid-phase platelet-dependent vascular occlusion agents. In particular, particles or coils or stents coated with platelet binding agents are directed to target vasculature, such as the vasculature of solid tumor masses or AV-malformations or aneurysms or endoleaks; the solid-phase agent then binds and activates platelets, which in turn bind and activate other platelets. This process results in the rapid formation of a platelet-mediated thrombus about the solid-phase agent causing vessel occlusion.
    Type: Application
    Filed: October 30, 2007
    Publication date: July 3, 2008
    Applicant: VIREXX MEDICAL CORP.
    Inventors: Michael W. Stewart, Antoine Noujiam, Roland H. Person